摘要
介绍我国放射性药物制备发展的初级、起步和快速发展三个阶段,从企业和医院的放射性药物生产和制备两个方面介绍目前放射性药物制备的现况,针对存在的问题,提出措施和建议。基于PSMA的放射性药物用于肿瘤诊断和治疗有可能成为热点,而中枢神经退行性疾病中,Tau蛋白显像剂的临床应用价值则更大。
The histrotry of radiopharmaceuticals development in China could be classified into three stages:the begining stage,the settelement stage and the rapid development stage.The current status of the preparation of radiopharmaceuticals from enterprises and hospitals was reviewed,and the measures and suggestions were put to resolve the problem which occurred in recent radiopharmaceuticals development.The research of development of PSMA based diagnostic and therapeutic radiopharmaceuticals would be hot spot.The Tau protein imaging will be more valuable in degenerative diseases of CNS.
作者
张锦明
杜进
ZHANG Jinming;DU Jin(Department of Nuclear Medicine,The PLA General Hospital,Beijing 100853,China;China Isotope & Radiation Corporation,Beijing 100045,China)
出处
《同位素》
CAS
2019年第3期178-185,I0003,共9页
Journal of Isotopes
关键词
放射性药物
诊断
治疗
显像剂
radiopharmaceuticals
diagnose
therapy
imaging agent
